Tsao P S, Lefer A M
Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Am J Physiol. 1990 Dec;259(6 Pt 2):H1660-6. doi: 10.1152/ajpheart.1990.259.6.H1660.
Isolated perfused rat hearts were subjected to global ischemia for 30 min followed by reperfusion for 2.5, 5, 10, or 20 min and then were tested for responsiveness to the endothelium-dependent vasodilator acetylcholine (ACh) and the endothelium-independent vasodilator nitroglycerin (NTG). ACh relaxation was impaired 2.5 min after reperfusion (32 +/- 3% of initial control, P less than 0.01) and remained comparably depressed at every time thereafter. No significant decrease in vasodilator response to NTG occurred at any time. Endothelial dysfunction was prevented by recombinant human superoxide dismutase (hSOD, 5 mg/heart) but not by the hydroxyl radical scavenger N-(2-mercaptopropionyl)-glycine (8 mg/heart). Comparable effects and a similar time course were observed in hypoxic hearts reoxygenated for periods up to 20 min. Chemiluminescence of perfusion effluent employed as an index of free radical production was measured at all postreperfusion times in ischemic hearts. Ischemia alone produced small increases in chemiluminescence. Reperfusion, however, produced significantly higher increases in chemiluminescence, with a large burst of activity at 0.25 min, which was blocked by hSOD. These findings suggest that endothelial dysfunction resulting in decreased release of endothelium-derived relaxing factor occurs very early after reperfusion or reoxygenation and may be due to the action of superoxide free radicals.
将离体灌注的大鼠心脏进行30分钟的全心缺血,然后再灌注2.5、5、10或20分钟,随后检测其对内皮依赖性血管舒张剂乙酰胆碱(ACh)和内皮非依赖性血管舒张剂硝酸甘油(NTG)的反应性。再灌注2.5分钟后ACh介导的舒张功能受损(为初始对照的32±3%,P<0.01),此后各时间点均保持类似程度的降低。对NTG的血管舒张反应在任何时间均未出现显著下降。重组人超氧化物歧化酶(hSOD,5mg/心脏)可预防内皮功能障碍,而羟基自由基清除剂N-(2-巯基丙酰基)-甘氨酸(8mg/心脏)则不能。在复氧长达20分钟的缺氧心脏中观察到了类似的效应和相似的时间进程。在缺血心脏再灌注后的所有时间点,均测量了用作自由基产生指标的灌注流出液的化学发光。单独缺血仅使化学发光略有增加。然而,再灌注使化学发光显著增加,在0.25分钟时出现大量活性爆发,这被hSOD阻断。这些发现表明,再灌注或复氧后很早即出现内皮功能障碍,导致内皮源性舒张因子释放减少,这可能是由于超氧自由基的作用所致。